GE HealthCare has announced positive results from a Phase I study of its manganese-based macrocyclic magnetic resonance imaging (MRI) contrast agent. Data from the first-in-human trial – presented at ...
Beacons for possible future dementia often go unnoticed because seeing them requires imaging technology only available in specialized research centers. The tide may soon turn, though. New developments ...
GE Healthcare Technologies, Inc. GEHC, in collaboration with the University of Cincinnati (UC), UC Health, and Cincinnati Children’s, has announced a cutting-edge initiative to accelerate MRI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results